Bleichroeder LP’s MAIA Biotechnology MAIA Stock Holding History

Bleichroeder LP’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$720K	Hold	500,000	–	–	0.13%	49
2026 Q1	$700K	Buy	+500,000	New	+$922K	0.12%	46

Other funds holding MAIA

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Bleichroeder LP's MAIA Position: Q2 2026 in Review

Bleichroeder LP held its MAIA Biotechnology (MAIA) position steady in Q2 2026 at 500,000 shares worth $720K. The position accounts for 0.13% of the portfolio, ranked #49.

Bleichroeder LP first reported a position in MAIA in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

Bleichroeder LP held 500,000 shares of MAIA Biotechnology worth $720K as of Q2 2026.
Bleichroeder LP left its MAIA Biotechnology share count unchanged in Q2 2026.
MAIA Biotechnology made up 0.13% of Bleichroeder LP's portfolio in Q2 2026, its #49 holding.
Bleichroeder LP first reported a position in MAIA Biotechnology in Q1 2026 and has held it in 2 quarters since.
36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.